LLyme disease patients may struggle with depression
Lyme disease depression symptoms are more common than many realize—and often misunderstood. In patients with chronic neurologic Lyme disease, depression frequently occurs alongside fatigue, headaches, cognitive difficulties, and joint pain.
One study found that more than one-third of patients with chronic neurologic Lyme disease experienced depression in addition to other physical and neurologic symptoms.
The Overlap Between Infection and Depression
Depression is not uncommon in chronic illness. However, it appears to be particularly prevalent in patients with Lyme disease.
Dr. Robert Bransfield, a psychiatrist specializing in tick-borne diseases, has reported that:
“Depression is the most common psychiatric syndrome associated with late-stage Lyme disease.”
This raises an important clinical question: are these symptoms purely psychological—or are they part of the disease process itself?
Beyond a Mental Health Diagnosis
Lyme disease can affect the central nervous system, leading to:
- Neuroinflammation
- Cognitive dysfunction
- Changes in mood and behavior
In this context, depression may reflect underlying biologic changes—not simply a reaction to illness.
The Role of Stigma
Patients with Lyme disease may face a dual burden:
- Managing complex physical symptoms
- Addressing psychiatric symptoms that may be misunderstood or dismissed
When clinicians attribute symptoms solely to psychological causes, patients may feel invalidated and overlooked.
This stigma can delay diagnosis, limit treatment options, and increase patient distress.
Why This Matters
The national conversation around depression highlights the importance of reducing stigma and improving access to care.
For Lyme disease patients, this includes recognizing that depression may be part of a broader medical condition.
Addressing both the physical and psychological aspects of illness is essential.
Clinical Perspective
Depression in Lyme disease should not be dismissed as unrelated to the underlying infection.
Clinicians should consider a comprehensive approach that evaluates neurologic, infectious, and psychiatric factors.
Early recognition and integrated care can improve outcomes and reduce the burden on patients.
Reference
- Bransfield RC. Suicide and Lyme and associated diseases. Neuropsychiatr Dis Treat. 2017;13:1575-1587.
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
